Renaissance Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Renaissance Pharmaceuticals's estimated annual revenue is currently $19.5M per year.
- Renaissance Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Renaissance Pharmaceuticals has 97 Employees.
- Renaissance Pharmaceuticals grew their employee count by -8% last year.
Renaissance Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $10.5M | 52 | -2% | N/A | N/A |
#2 | $354.3M | 461 | -2% | $567.1M | N/A |
#3 | $379.5M | 1888 | -6% | N/A | N/A |
#4 | $6.8M | 34 | -6% | N/A | N/A |
#5 | $5.4M | 27 | 0% | N/A | N/A |
#6 | $39.4M | 196 | 15% | N/A | N/A |
#7 | $37.4M | 186 | -6% | N/A | N/A |
#8 | $7M | 35 | 3% | N/A | N/A |
#9 | $13.5M | 67 | -11% | N/A | N/A |
#10 | $10.9M | 54 | 0% | N/A | N/A |
What Is Renaissance Pharmaceuticals?
Renaissance Pharmaceuticals is a pharmaceuticals company based out of 17 Battery Pl Rm 306, New York, New York, United States.
keywords:N/A
N/A
Total Funding
97
Number of Employees
$19.5M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Renaissance Pharmaceuticals News
Equities research analysts expect NeuroBo Pharmaceuticals, ... Renaissance Technologies LLC acquired a new stake in shares of NeuroBo...
Renaissance Technologies LLC now owns 1,223,102 shares of the company's stock valued at $373,000 after acquiring an additional 97,600 shares...
Renaissance Technologies LLC owned approximately 8.53% of Quoin Pharmaceuticals as of its most recent filing with the Securities & Exchange...
Satsuma Pharmaceuticals, a clinical-stage biotech developing a therapy for ... Renaissance Capital's Renaissance IPO ETF (symbol: IPO) ...
On Friday, shares of Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) marked ... In the meanwhile, Renaissance Technologies LLC also increased ...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $19.8M | 97 | 11% | N/A |
#2 | $12.6M | 97 | -3% | $13.8M |
#3 | $14.1M | 97 | 2% | $97.4M |
#4 | $22.1M | 97 | 9% | $34.4M |
#5 | $17.5M | 97 | 21% | N/A |
Renaissance Pharmaceuticals Executives
| Name | Title |
|---|---|
| Daniel Brennan | Vice President, Quality |